KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $20.1 million.

  • Medpace Holdings' Other Working Capital Changes fell 4939.72% to $20.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $143.8 million, marking a year-over-year decrease of 459.11%. This contributed to the annual value of $143.8 million for FY2025, which is 459.11% down from last year.
  • Per Medpace Holdings' latest filing, its Other Working Capital Changes stood at $20.1 million for Q4 2025, which was down 4939.72% from $25.5 million recorded in Q3 2025.
  • Medpace Holdings' Other Working Capital Changes' 5-year high stood at $80.6 million during Q2 2025, with a 5-year trough of -$15.0 million in Q1 2023.
  • Its 5-year average for Other Working Capital Changes is $27.5 million, with a median of $26.9 million in 2023.
  • Per our database at Business Quant, Medpace Holdings' Other Working Capital Changes surged by 29567306.19% in 2022 and then tumbled by 23420973.89% in 2023.
  • Quarter analysis of 5 years shows Medpace Holdings' Other Working Capital Changes stood at $40.8 million in 2021, then increased by 9.83% to $44.8 million in 2022, then dropped by 8.25% to $41.1 million in 2023, then fell by 3.55% to $39.6 million in 2024, then crashed by 49.4% to $20.1 million in 2025.
  • Its Other Working Capital Changes stands at $20.1 million for Q4 2025, versus $25.5 million for Q3 2025 and $80.6 million for Q2 2025.